Related Experiment Videos
Mucinous differentiation in prostatic adenocarcinoma.
J E McNeal1, J Alroy, A Villers
1Division of Urology, Stanford University School of Medicine, CA 94305-5118.
Human Pathology
|October 1, 1991
Summary
This study investigates mucin-secreting prostate cancer patterns, identifying "colloid carcinoma" as a potential variant of Gleason grade 4 cancer. It also describes novel collagenous stromal micronodules linked to mucus hypersecretion.
Area of Science:
- Uropathology
- Cancer Biology
- Histopathology
Background:
- Mucin secretion is observed in a subset of prostate carcinomas.
- Understanding these mucinous patterns is crucial for accurate cancer grading and prognosis.
Purpose of the Study:
- To characterize the morphologic and histochemical features of mucin-secreting prostate carcinomas.
- To investigate the relationship between mucinous differentiation and Gleason grading.
- To identify novel histopathological patterns associated with mucin secretion.
Main Methods:
- Morphologic and histochemical analysis of 33 mucin-secreting prostate carcinomas from radical prostatectomy specimens.
- Lectin and immunohistochemical staining to analyze mucin composition and differentiation antigens.
Main Results:
- Gleason grade 3 with luminal distention was the most common mucin-secreting pattern.
- "Colloid carcinoma" with mucinous lakes was unique to mucinous areas and associated with cribriform Gleason grade 4.
- Previously undescribed collagenous stromal micronodules were found in 13 cases, potentially as a stromal reaction to extraluminal mucin.
- Histochemical staining revealed similar acidic mucin composition across cases.
- Immunohistochemistry showed downregulation of differentiation antigens in mucinous areas.
Conclusions:
- "Colloid carcinoma" may represent a variant of Gleason grade 4 prostate cancer due to mucus hypersecretion.
- Collagenous stromal micronodules are a novel finding associated with mucin secretion, particularly in grade 3 and grade 4 patterns.
- Mucinous differentiation in prostate cancer is accompanied by altered expression of differentiation antigens.